DNTH
Price
$20.40
Change
+$0.05 (+0.25%)
Updated
Jul 18 closing price
Capitalization
656.06M
MMIRF
Price
$0.01
Change
-$0.04 (-80.00%)
Updated
Jul 3 closing price
Capitalization
38.31M
Interact to see
Advertisement

DNTH vs MMIRF

Header iconDNTH vs MMIRF Comparison
Open Charts DNTH vs MMIRFBanner chart's image
Dianthus Therapeutics
Price$20.40
Change+$0.05 (+0.25%)
Volume$494.63K
Capitalization656.06M
Medmira
Price$0.01
Change-$0.04 (-80.00%)
Volume$250
Capitalization38.31M
DNTH vs MMIRF Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. MMIRF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and MMIRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (DNTH: $20.40 vs. MMIRF: $0.01)
Brand notoriety: DNTH and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 157% vs. MMIRF: 3%
Market capitalization -- DNTH: $656.06M vs. MMIRF: $38.31M
DNTH [@Biotechnology] is valued at $656.06M. MMIRF’s [@Biotechnology] market capitalization is $38.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, both DNTH and MMIRF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while MMIRF’s TA Score has 4 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 5 bearish.
  • MMIRF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MMIRF is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +1.69% price change this week, while MMIRF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($656M) has a higher market cap than MMIRF($38.3M). MMIRF YTD gains are higher at: 6.870 vs. DNTH (-6.422). MMIRF has higher annual earnings (EBITDA): -3.24M vs. DNTH (-116.76M). DNTH has more cash in the bank: 263M vs. MMIRF (18.3K). DNTH has less debt than MMIRF: DNTH (1.4M) vs MMIRF (10.2M). DNTH has higher revenues than MMIRF: DNTH (6.52M) vs MMIRF (254K).
DNTHMMIRFDNTH / MMIRF
Capitalization656M38.3M1,713%
EBITDA-116.76M-3.24M3,608%
Gain YTD-6.4226.870-93%
P/E Ratio3.24N/A-
Revenue6.52M254K2,569%
Total Cash263M18.3K1,437,158%
Total Debt1.4M10.2M14%
FUNDAMENTALS RATINGS
DNTH vs MMIRF: Fundamental Ratings
DNTH
MMIRF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
5198
P/E GROWTH RATING
1..100
66100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is somewhat better than the same rating for DNTH (52). This means that MMIRF’s stock grew somewhat faster than DNTH’s over the last 12 months.

DNTH's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for MMIRF (100). This means that DNTH’s stock grew somewhat faster than MMIRF’s over the last 12 months.

DNTH's SMR Rating (95) in the null industry is in the same range as MMIRF (100). This means that DNTH’s stock grew similarly to MMIRF’s over the last 12 months.

DNTH's Price Growth Rating (51) in the null industry is somewhat better than the same rating for MMIRF (98). This means that DNTH’s stock grew somewhat faster than MMIRF’s over the last 12 months.

DNTH's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for MMIRF (100). This means that DNTH’s stock grew somewhat faster than MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DNTHMMIRF
RSI
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
70%
Momentum
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
67%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVGAF0.100.03
+35.14%
Silver Grail Resources Ltd.
HENOF79.23N/A
N/A
Henkel AG & Co. KGAA
GRGCF28.00N/A
N/A
GEORGIA CAPITAL PLC
ORINY38.88N/A
N/A
Orion Corporation OY
TPBTF0.08N/A
N/A
Betmakers Technology Group Ltd.

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.25%
IMNM - DNTH
53%
Loosely correlated
+1.24%
XNCR - DNTH
51%
Loosely correlated
-1.10%
ERAS - DNTH
51%
Loosely correlated
+0.67%
CRNX - DNTH
49%
Loosely correlated
-5.78%
OCUL - DNTH
48%
Loosely correlated
-0.44%
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and SGMT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and SGMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
SGMT - MMIRF
32%
Poorly correlated
-1.47%
NWPHF - MMIRF
29%
Poorly correlated
N/A
VTYX - MMIRF
26%
Poorly correlated
-3.21%
AXSM - MMIRF
21%
Poorly correlated
-0.48%
DNTH - MMIRF
21%
Poorly correlated
+0.25%
More